December 2025

34 Articles

No Section

Serum transthyretin in ATTR-CM: A pragmatic biomarker edging toward prime time

25 September 2025
Author(s): Alberto Aimo, Vincenzo Castiglione, Giuseppe Vergaro

Over the last decade, transthyretin amyloid cardiomyopathy (ATTR-CM) has shifted toward earlier recognition and routine use of disease-modifying therapy, heightening the need for biomarkers that are... more

Beyond the Guidelines

Managing invasive fungal infections in critical illness: reflections on recent American Thoracic Society recommendations

16 October 2025
Author(s): Claudia Bartalucci, Jon Salmanton-García, Antonio Vena

The global burden of invasive fungal diseases (IFDs) continues to increase, particularly among critically ill patients, where mortality remains high —reaching up to 70 %— despite major advances in... more

Repositioning beta-blocker therapy after acute myocardial infarction

8 October 2025
Author(s): José A. Barrabés, Aitor Uribarri

Beta-blockers have long been prescribed for secondary prevention in patients with acute myocardial infarction (MI) after clinical trials performed in the 1980′s demonstrated that their use provided... more

Commentary

From words to biomarkers: Why PEth should enter clinical practice when assessing the risk of venous thromboembolism

22 October 2025
Author(s): Elena Campello, Erika Zola, Paolo Simioni

Alcohol consumption remains one of the most pervasive and modifiable risk factors influencing global health. Its dualistic nature—protective in moderation, harmful in excess—has long fascinated... more

Prevention of venous thromboembolism in critically ill patients: current state and future perspectives

9 October 2025
Author(s): Valentine Mismetti, Patrick Mismetti, Laurent Bertoletti

Venous thromboembolic disease (VTE) is a major complication of intensive care, responsible for significant morbidity and mortality. It remains a constant challenge for clinicians because of the... more

Venous thromboembolism provoked by transient risk factors in women: Towards improved personalized risk assessment

1 October 2025
Author(s): Luuk J.J. Scheres, Jenneke Leentjens, Saskia Middeldorp

The occurrence of venous thromboembolism (VTE) in young women is a scenario frequently encountered in clinical practice. In this population, a VTE event is often associated with provoking risk... more

Treatment target of blood pressure: Changes in evidence-based guidelines and impact of measurement conditions

8 September 2025
Author(s): Kei Asayama, Takayoshi Ohkubo

Although exceptions exist, the general prognostic benefit of antihypertensive drug treatment is definite. With the accumulation of relevant evidence, the target blood pressure level of... more

Internal Medicine Flashcard

Xanthelasma, arcus senilis, and supravalvular aortic stenosis

9 October 2025
Author(s): Ashishpreet Singh, Suraj Kumar, Bhupinder Singh

A 28-year-old female presented with 12 months of progressive dyspnea and 6 months of exertional angina, now limiting daily activities. On examination (Fig. 1; Panel A), she had xanthelasma, arcus... more

Bilateral ocular motility impairment

9 October 2025
Author(s): Keizo Tanitame, Nobuko Tanitame

An 82-year-old man was referred to the Diagnostic Imaging Center with progressive bilateral ocular motility impairment and diplopia, which had gradually worsened over the past three months, with... more

Ataxia, dysarthria and brainstem lesions in an elderly patient: a diagnostic challenge

25 August 2025
Author(s): Daniela Zermeño-Napolitano, Rodrigo Villaseñor-Echavarri, Latife Salame Khouri

A 75-year-old Hispanic man presented with a 3-year history of frequent falls conditioned by gait instability and generalized weakness. His symptoms progressed with worsening of gait imbalance,... more

Letter to the Editor

Managing psoriasis in patients with lupus: A complex challenge

3 November 2025
Author(s): Margarida Lucas Rocha, Ivânia Soares, Vítor Silvestre-Teixeira, Paulo Filipe

Psoriasis is a common, chronic, and relapsing scaly erythematous skin disease, occurring worldwide at any age, with no clear gender predilection. It shows a bimodal age distribution, with incidence... more

Activation state of peripheral T lymphocytes predicts response to abatacept in patients with IgG4-related disease

3 November 2025
Author(s): Claudia Minici, Jasmin Mahajne, Ugo Orfanelli, Marco Lanzillotta, Emanuel Della-Torre

Dear Editor,

Authors of individual participant data meta-analyses must honor trialists’ commitments to trial participants: a case study

10 October 2025
Author(s): Rafael Dal-Ré

The need to respect the trial participants’ willingness regarding the secondary use of their data to conduct research such as meta-analyses has been recently discussed [1]. The best approach is to... more

Severe acute refractory hyperkalaemia associated with liposomal amphotericin B infusion

7 October 2025
Author(s): Gabriëlla von Kreijfelt, Linda Davidson, Yara Joanne Holtrust, Maarten Arends, Juliëtte Zwaveling

Dear editor,

Pharma’s subtle conditioning in clinical medicine

5 October 2025
Author(s): Nicola Mumoli, Lucia Colavolpe, Francesco Cei

The relationship between physicians and the pharmaceutical industry continues to provoke debate, often framed around conflicts of interest and the potential for undue influence on prescribing... more

Association between sPESI score and 90-day hospital readmissions in patients with acute pulmonary embolism

29 September 2025
Author(s): Kwadwo O. Bonsu, Rufaro S. Chitsike, Tiffany A. Lee, Hai V. Nguyen, Stephanie W. Young

Pulmonary embolism (PE) is a leading cause of cardiovascular morbidity and mortality, with 10–30 % of patients dying within one month of diagnosis [1]. Early risk stratification can aid clinicians in... more

Association of prevalence of hypertension and its subtypes with short-term weight change

24 September 2025
Author(s): Haonan Li, Jieying Shi, Jialin Wen, Juan Luo, Yi Zhang

Obesity is a well-established risk factor for hypertension, and produces various hemodynamic abnormalities that may impact hypertension subtypes [1]. From 2011 to 2020, obesity prevalence in the US... more

Aetiology of inflammatory abdominal aortic aneurysms influences prognosis

5 September 2025
Author(s): Océane Rieux, Marie Morard, Antoine Benichou, Loubna Dari, Olivier Espitia

Abdominal aortic aneurysms (AAA) affect approximately 5 % of male over the age of 65 [1]. Among these, 5 % to 10 % are classified as inflammatory AAA (IAAA) [2]. A wide range of underlying... more

Association of social isolation with excess mortality risk and life expectancy in people with prediabetes and diabetes

27 August 2025
Author(s): Rui Chen, Ying Zhou, Xiaoxv Yin

Diabetes affects 589 million adults globally and significantly increases mortality risk by 1.6- to 2-fold, with an additional 1.1 billion people estimated to have early-stage glucose metabolism... more

Original Article

The Implementation of the Acute Basic Palliation Concept in Newly introduced Hospital Departments: An Explorative Observational Study of Non-Specialized Palliative Patients Discharged to Die at Home in Denmark

29 August 2025
Author(s): Dorte Melgaard, Matilde Alida Arendt Eriksen, Jakob Fogh Jørgensen, Harman Yonis, Rikke Bramming, Laurits Dalsgaard, Camilla Ly, Bensu Izgi, Annika Kamp, Natasja Uldall, Luise Lilleøre, Maiken Faklam Dalsgaard Knudsen, Marte Brenna Steinbakken, Christian Bille, Kalle Lindbjerg, Julie Bjerke, Abeda Samadi, Anne Lund Krarup

Palliative Care (PC) is a key component of patient-centred healthcare, focusing on relieving the symptoms, pain, dignity and stress of patients with serious, life-limiting conditions. A widely... more

Long term fluid volume fluctuations and mortality in kidney failure patients on long term hemodialysis treatment

16 August 2025
Author(s): Carmine Zoccali, Giovanni Tripepi, Paola Carioni, Francesca Mallamaci, Matteo Savoia, Len A. Usvyat, Franklin W. Maddux, Stefano Stuard

The prognosis of patients kidney failure (KF) patients on long term hemodialysis treatment is one of the most severe among chronic diseases, and only modest progress has been made over the last... more

Bleeding risk on rivaroxaban versus apixaban in older patients with venous thromboembolism: a nationwide observational register-based study

11 August 2025
Author(s): Maria Roupe, Annika Rosengren, Aldina Pivodic, Rebecka Bertilsson, Jacob Philipson, Kristina Svennerholm, Mazdak Tavoly, Katarina Glise Sandblad

During primary treatment, apixaban was associated with a lower risk of major bleeding than rivaroxaban without a corresponding increase in recurrent PE risk. During secondary treatment, no difference... more

Venous thromboembolism associated with infections: a systematic review and meta-analysis

7 August 2025
Author(s): Panagiotis Stathopoulos, Stelios-Elion Bousi, Marinos Zachiotis, Athanasios Lampropoulos, Stylianos A. Kakoullis, Charalambos Michaeloudes, Matthew E. Falagas

Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), has long been a significant cause of severe disease and death. At the same time, its etiology is... more

A prospective study of the association between phosphatidylethanol concentration and risk of first-ever venous thromboembolism

2 August 2025
Author(s): Magdalena Johansson, Anders Själander, Marcus M Lind, Lars Johansson

Venous thromboembolism (VTE) is a common term for deep vein thrombosis (DVT) and pulmonary embolism. The overall incidence rate of VTE in adults is 1–2 per 1000 person-years and has increased... more

Transthyretin serum levels and clinical outcomes in patients with transthyretin amyloid cardiomyopathy

29 July 2025
Author(s): Annamaria Minervini, Gonzalo Barge-Caballero, Andrea López-López, Manuel López-Pérez, Eva González-Babarro, Inés Gómez-Otero, Raquel Bilbao-Quesada, Mario Gutiérrez-Feijoo, Alfonso Varela-Román, Alberto Bouzas-Mosquera, María G. Crespo-Leiro, Eduardo Barge-Caballero

Over the last decade, significant advances have been made regarding the knowledge of the biological bases, diagnosis and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM), which currently... more

Whether an optimal strategy exists for VTE prevention in critically ill patients: Insights from guidelines and randomized controlled trials

25 July 2025
Author(s): Di Wei, Sinan Ma, Weijia Huang, Ting Yang, Keyu Chen, Baoni Sun, Xinye Li, Li Zhang, Yan Wang

Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a significant concern in critically ill patients. Effective prevention is vital due to its high... more

Performance of enhanced liver fibrosis test and indirect serum fibrosis markers for exclusion of advanced liver fibrosis in alpha-1 antitrypsin deficiency

24 July 2025
Author(s): Naomi N. Kappe, Malin Fromme, Jan Stolk, Ilaria Ferrarotti, Pavel Strnad, Bart van Hoek

Alpha-1 antitrypsin deficiency (AATD) is a hereditary condition caused by mutations in the SERPINA1 gene, encoding alpha-1 antitrypsin (AAT), an important antiprotease in the lungs that is primarily... more

Baseline risk and outcome benefit from intensive blood pressure targeting. A systematic review

16 July 2025
Author(s): Paolo Verdecchia, Fabio Angeli, Gianpaolo Reboldi

The definition of blood pressure (BP) targets in treated hypertensive patients remains controversial. Some Guidelines recommend an ideal systolic BP target of <140 mmHg, with different targets... more

Venous thromboembolism associated with weak transient risk factors in young women: risk of late recurrence. An international cohort study

12 July 2025
Author(s): Victoria Bitsadze, Mariya Gennadevna Nikolaeva, Eve Mousty, Jamilya Khizroeva, Jeremy Laurent, Sylvie Ripart, Lorris Le Collen, Salim Allal, Mathieu Fortier, Sylvie Bouvier, Mathias Chea, Antonia Perez-Martin, Alexander Makatsariya, Jean-Christophe Gris

After a first episode of venous thromboembolism (VTE) treated according to the guidelines, the risk of thrombotic recurrence must be assessed in order to guide medical treatment. The clinical risk... more

Review Article

Crystal clear – Part II: the role of uric acid in cardiorenal disease

17 October 2025
Author(s): Claudio Borghi, Federica Fogacci, Arrigo FG Cicero

Building on the foundational mechanistic and epidemiological knowledge from Part I, this second part of the review further unpacks the cardiovascular implications of abnormalities in serum levels of... more

Fever and inflammation of unknown origin in the 21st century

20 August 2025
Author(s): Christina Antoniadou, Efstratios Gavriilidis, Petros Chatzopoulos, Maria Gkouliavera, Panagiotis Skendros

Fever of unknown origin (FUO) and inflammation of unknown origin (IUO) are among the most complex and challenging clinical syndromes in Internal Medicine. Internists, by virtue of their broad... more

Charting the future of AL amyloidosis: Diagnostic advancements, prognostic insights, and therapeutic challenges

8 August 2025
Author(s): Xiayin Li, Jiecong Wu, Qing Huang, Wanting Zheng, Lu Huang, Changhao Han, Chunyu Zhang, Zhichun Gan, Yan Xing, Shiren Sun

Light-chain (AL) amyloidosis is a form of plasma cell dyscrasias characterized by deposition of misfolded monoclonal immunoglobulin light chain-derived amyloid fibrils, resulting in abnormal... more

Crystal clear – part I: The role of uric acid in cardiorenal disease

27 July 2025
Author(s): Claudio Borghi, Federica Fogacci, Arrigo FG Cicero

Uric acid (UA), the terminal product of purine catabolism in humans, arises from both endogenous nucleic acid turnover and exogenous sources—particularly diets rich in animal protein and fructose.... more

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness